Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 16 Jun 2023 for Prometheus Biosciences, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Keith W. Marshall: trading record in brief
Keith W. Marshall has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Prometheus Biosciences, Inc. and Histogen Inc. In total, 13 filings cover trades dated from 22 May 2020 to 16 June 2023.
The open-market record consists of 4 sales worth €3.2M, with no purchase. Besides market trades, the filings include 2 share grants and 6 option exercises. So far in 2023, the count stands at no purchases and 4 sales.
The newest entry dates from 16 June 2023: a transaction, in Prometheus Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Keith W. Marshall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
87,973 sharesCommon StockSEC:0000899243-23-015754:0
78,162 shares@ US$3.1068.6% of flowCommon StockSEC:0001209191-23-034038:0
10,000 shares@ US$3.7010.3% of flowCommon StockSEC:0001209191-23-023869:0
10,000 shares@ US$3.7010.6% of flowCommon StockSEC:0001209191-23-017435:0
5,000 shares@ US$3.705.2% of flowCommon StockSEC:0001209191-23-010974:0
5,000 shares@ US$3.705.2% of flowCommon StockSEC:0001209191-23-004138:0
9,811 shares0Common StockSEC:0001209191-22-061089:0
7 of 7 declarations
